Manufacturing

Feliza Mirasol is the science editor for 

Videos

At AAPS PharmSci 360.Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed trends in new analytical tools for RNA characterization and gave highlights from his presentation.

Discussing Trends in New Analtyical Tools for RNA (AAPS PharmSci 360)

Chris Spivey is the editorial director of 

Under a pilot program initiative introduced by the Biden administration, Aaron Cowley, chief scientific officer, ReciBioPharm, talked about the ongoing progress in developing continuous manufacturing for mRNA.

Biopharma’s Progress with Continuous Manufacturing in mRNA (BIO 2024)

Christian Cobaugh, CEO and founder of Vernal Biosciences, considers the outsourcing landscape for mRNA production.

A Look at the Outsourcing Landscape for mRNA (BIO 2024)

Articles

The Mirus Bio acquisition will boost Merck KGaA’s viral vector manufacturing services. 

Merck KGaA Set to Acquire Mirus Bio in $600 Million Deal

The collaboration will target solid tumors using Poseida’s allogeneic CAR-T platform to develop convertibleCAR programs.

Astellas and Poseida Therapeutics Partner to Develop Allogeneic Cell Therapies

In back-to-back deals, Charles River will offer plasmid DNA manufacturing services for a gene therapy under development by Axovia Therapeutics and for a lead candidate being developed by Ship of Theseus.

Charles River Enters pDNA Manufacturing Deals with Axovia Therapeutics and Ship of Theseus

Patrick Thiavilleis chief technology officer of Exothera.

Innovation in this space depends on strategizing for GMP compliance and market access.

Driving Innovation in Nucleic Acid Therapeutics

CordenPharma’s new starter kits are designed to enable effective formulation in the development of mRNA-based therapeutics.

CordenPharma Launches New LNP Starter Kits for mRNA Formulation

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

Lonza and Oxford Nanopore Partner on mRNA Analytics

The success of mRNA-based vaccines paves the way for mRNA in oncology and beyond.

Manufacturing, Nucleic Acids